Wnt-3a hFc Chimera, Human
| $375.00 | |
| Z03815-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $375.00 | |
| Z03815-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human |
| Purity | > 95% as determined by Bis-Tris PAGE |
| Endotoxin Level | Less than 1 EU per μg by the LAL method. |
| Biological Activity | Wnt-3a hFc Chimera, Human (Cat.No.: Z03815) can induce Topflash reporter activity in HEK293T human embryonic kidney cells. |
| Expression System | HEK293 |
| Theoretical Molecular Weight | 58.50 kDa. |
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 60-75 kDa based on Bis-Tris PAGE result. |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Wnt-3a hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Measured by its ability to induce Topflash reporter activity in HEK293T human embryonic kidney cells. The ED50 for this effect is 2-12 ng/mL. »
| Target Background | Wnt-3a activates the canonical Wnt signaling pathway and is expressed in the dorsal midline region, playing a crucial role in spinal cord development. Additionally, it regulates autophagy, apoptosis, neuron regeneration, neurogenic inflammation, and axon regeneration. Wnt-3a promotes the beta-catenin/Tcf pathway, which can induce tumors and lead to cancer in specific cell populations. Moreover, it is widely used in cytokine for organoid construction. |
| Synonyms | Wnt-3a; Wnt 3a; WNT3A protein; Wnt3a |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.